Versant Venture Management
Latest statistics and disclosures from Versant Venture Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are LENZ, GLUE, JBIO, CRSP, SKYE, and represent 92.42% of Versant Venture Management's stock portfolio.
- Added to shares of these 1 stock: LENZ (+$124M).
- Started 1 new stock position in LENZ.
- Reduced shares in these 1 stock: CRSP (-$23M).
- Versant Venture Management was a net buyer of stock by $101M.
- Versant Venture Management has $213M in assets under management (AUM), dropping by 158.66%.
- Central Index Key (CIK): 0001560009
Tip: Access up to 7 years of quarterly data
Positions held by Versant Venture Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Versant Venture Management
Versant Venture Management holds 9 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Lenz Therapeutics Common Stock (LENZ) | 58.3 | $124M | NEW | 2.7M | 46.58 |
|
| Monte Rosa Therapeutics Common Stock (GLUE) | 19.7 | $42M | 5.7M | 7.41 |
|
|
| Jade Biosciences Common Stock (JBIO) | 6.2 | $13M | 1.5M | 8.63 |
|
|
| CRISPR Therapeutics Common Shares (CRSP) | 4.5 | $9.6M | -70% | 149k | 64.81 |
|
| Skye Bioscience Common Stock (SKYE) | 3.7 | $7.9M | 2.0M | 3.93 |
|
|
| Contineum Therapeutics Common Stock (CTNM) | 3.0 | $6.4M | 543k | 11.75 |
|
|
| Repare Therapeutics Common Stock (RPTX) | 2.2 | $4.7M | 2.6M | 1.76 |
|
|
| Tempest Therapeutics Common Stock | 1.3 | $2.8M | 270k | 10.28 |
|
|
| Adverum Biotechnologies Common Stock | 1.1 | $2.3M | 507k | 4.53 |
|
Past Filings by Versant Venture Management
SEC 13F filings are viewable for Versant Venture Management going back to 2014
- Versant Venture Management 2025 Q3 filed Nov. 10, 2025
- Versant Venture Management 2025 Q2 filed Aug. 11, 2025
- Versant Venture Management 2025 Q1 filed May 7, 2025
- Versant Venture Management 2024 Q4 filed Feb. 12, 2025
- Versant Venture Management 2024 Q3 filed Nov. 8, 2024
- Versant Venture Management 2024 Q2 filed Aug. 7, 2024
- Versant Venture Management 2024 Q1 filed May 3, 2024
- Versant Venture Management 2023 Q4 filed Feb. 8, 2024
- Versant Venture Management 2023 Q3 filed Nov. 3, 2023
- Versant Venture Management 2023 Q2 filed Aug. 9, 2023
- Versant Venture Management 2023 Q1 filed May 11, 2023
- Versant Venture Management 2022 Q4 filed Feb. 9, 2023
- Versant Venture Management 2022 Q3 filed Nov. 10, 2022
- Versant Venture Management 2022 Q2 filed Aug. 11, 2022
- Versant Venture Management 2022 Q1 filed May 10, 2022
- Versant Venture Management 2021 Q4 filed Feb. 11, 2022